PIPERNO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 16.195
EU - Europa 6.298
AS - Asia 3.414
SA - Sud America 234
AF - Africa 28
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.186
Nazione #
US - Stati Uniti d'America 15.915
SG - Singapore 1.233
CN - Cina 1.173
SE - Svezia 1.053
IE - Irlanda 961
DE - Germania 915
UA - Ucraina 827
IT - Italia 746
RU - Federazione Russa 668
HK - Hong Kong 633
GB - Regno Unito 369
CA - Canada 265
FI - Finlandia 209
BR - Brasile 189
AT - Austria 130
FR - Francia 129
IN - India 83
VN - Vietnam 74
TR - Turchia 63
BE - Belgio 62
NL - Olanda 59
DK - Danimarca 58
ID - Indonesia 41
BG - Bulgaria 28
JP - Giappone 22
PL - Polonia 14
IR - Iran 13
RO - Romania 12
AR - Argentina 11
KR - Corea 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
LT - Lituania 9
PE - Perù 9
PK - Pakistan 9
MX - Messico 8
TW - Taiwan 8
AU - Australia 7
CH - Svizzera 6
EG - Egitto 6
EU - Europa 6
IQ - Iraq 6
UZ - Uzbekistan 6
CL - Cile 5
CO - Colombia 5
ES - Italia 5
GR - Grecia 5
MA - Marocco 5
MY - Malesia 5
NO - Norvegia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
BO - Bolivia 3
DZ - Algeria 3
KE - Kenya 3
MD - Moldavia 3
PH - Filippine 3
SC - Seychelles 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
ZM - Zambia 1
Totale 26.186
Città #
Ann Arbor 3.013
Woodbridge 1.748
Fairfield 1.438
Houston 1.327
Chandler 1.026
Dublin 929
Jacksonville 906
Singapore 808
Ashburn 750
Wilmington 746
Hong Kong 626
Frankfurt am Main 623
Seattle 573
Dearborn 565
Cambridge 514
Princeton 361
New York 320
Santa Clara 311
Nanjing 236
Milan 222
Lawrence 174
Shanghai 169
Lachine 155
Altamura 134
Vienna 120
Beijing 106
San Diego 93
Nanchang 74
Andover 67
Council Bluffs 64
Shenyang 64
Hebei 54
Brussels 52
Guangzhou 49
Dong Ket 47
Los Angeles 47
Toronto 47
Boardman 45
Helsinki 45
Ottawa 44
Jinan 42
Changsha 40
Jiaxing 39
Jakarta 37
Falls Church 35
Tianjin 35
Zhengzhou 26
Dallas 25
London 24
Mountain View 24
Norwalk 24
Fremont 23
Ningbo 23
Nuremberg 21
Plovdiv 21
Belo Horizonte 20
Huizen 19
Rome 17
Auburn Hills 16
Hefei 16
Kunming 16
Philadelphia 16
São Paulo 16
Turin 15
Taizhou 14
Hangzhou 12
Munich 12
Pune 12
Chengdu 11
Kocaeli 11
Lissone 11
Verona 10
Detroit 9
Edmonton 9
Phoenix 9
Washington 9
Chicago 8
Chiswick 8
Kilburn 8
Paris 8
Redmond 8
San Francisco 8
San Mateo 8
Segrate 8
University Park 8
Waanrode 8
Fuzhou 7
Monmouth Junction 7
Rio de Janeiro 7
Chongqing 6
Clarks Summit 6
Kiev 6
Lanzhou 6
Lecco 6
Lima region 6
Loreto 6
Monza 6
Pavia 6
Sofia 6
Venezia 6
Totale 19.578
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 435
Hepcidin regulation in a mouse model of acute hypoxia 401
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 312
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 297
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 287
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 266
Juvenile Hemochromatosis 252
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 247
Hif1a: A putative modifier of hemochromatosis 229
Inherited iron overload disorders 226
Hepcidin regulation in a mouse model of acute hypoxia 215
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 210
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 210
Type 3 hemochromatosis and beta-thalassemia trait 205
Early impairment of large artery structure and function in Type I diabetes mellitus 204
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2. 203
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 203
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 200
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 196
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 196
Circulating factors are involved in hypoxia-induced hepcidin suppression 195
Unexplained isolated hyperferritinemia without iron overload 193
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 192
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 190
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 190
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 190
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 186
Hyperferritinemia and diagnosis of type 1 Gaucher disease 185
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 184
Hepatocellular carcinoma in Gaucher disease: an international case series 183
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 178
The iron status of Italian subjects with beta-thalassemia trait 176
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 175
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 173
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 173
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 173
Biochemical and genetic defects underlying human congenital hypotransferrinemia 173
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 172
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 171
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 170
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 170
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 169
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 168
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 168
Ferroportin disease: A novel SLC40A1 mutation 168
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 168
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 167
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 167
Homozygous deletion of HFE: The Sardinian hemochromatosis? 166
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 166
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 165
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 164
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 163
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 162
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 161
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 160
Erythrocyte ferritin in patients on chronic hemodialysis treatment 159
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 158
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 158
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 158
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 158
Erythrocyte ferritin in thalassemia syndromes 157
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 157
Different cortical excitability profiles in hereditary brain iron and copper accumulation 157
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 155
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 154
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 153
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 152
Myelodysplastic Syndromes and Iron Chelation Therapy 152
Increased serum ferritin is common in men with essential hypertension 151
Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene 151
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 151
Idiopathic haemochromatosis and HLA antigens in Italy: is A3 Bw35 HLA haplotype a marker for idiopathic haemochromatosis gene in north east regions? 150
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 150
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 150
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 150
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 150
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 149
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 149
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 147
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 147
Natural history of juvenile haemochromatosis 145
Factors affecting erythrocyte ferritin content in thalassaemia intermedia 144
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 144
Haemochromatosis in patients with β-thalassaemia trait 143
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 143
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia 143
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisons 142
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 141
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (c70r) 140
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 140
Liver iron influences the response to interferon alpha therapy in chronic hepatitis C 140
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 138
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 137
Novel human pathological mutations. Gene symbol: ALPL. Disease: hypophosphatasia. 137
Saturability of hepatic iron deposits in genetic hemochromatosis 137
Liver iron concentration in chronic viral hepatitis: a study of 98 patients 137
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 136
Iron metabolism in thalassemia and sickle cell disease 135
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 135
Totale 17.748
Categoria #
all - tutte 94.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020572 0 0 0 0 0 0 0 0 0 202 295 75
2020/20212.953 233 129 338 327 244 200 265 190 252 361 179 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20253.539 396 675 231 241 565 176 225 288 740 2 0 0
Totale 26.954